(Q43459999)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20425077%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Novel perspectives for the treatment of gastric cancer: from a global approach to a personalized strategy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20425077%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20425077%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Rossana Berardi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20425077%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Mirco Pistelli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20425077%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Luca Faloppi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20425077%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Stefano Cascinu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20425077%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

4

Riccardo Giampieri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20425077%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

3

Alessandro Bittoni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20425077%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

8

Michela Del Prete

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20425077%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Eva Galizia

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20425077%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

1 May 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20425077%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

published in

Current Oncology Reports

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20425077%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20425077%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20425077%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

175-185

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20425077%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11912-010-0101-8

1 February 2020

exact match

0 references

cites work

Pomalidomide is active in the treatment of anemia associated with myelofibrosis

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-010-0101-8

Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente).

21 January 2018

1 reference

12 December 2020

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

1 reference

12 December 2020

Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.

1 reference

12 December 2020

A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer

1 reference

12 December 2020

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.

1 reference

12 December 2020

Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group

1 reference

12 December 2020

Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.

1 reference

12 December 2020

Phase I dose-finding study of sorafenib in combination with capecitabine and cisplatin as a first-line treatment in patients with advanced gastric cancer

1 reference

12 December 2020

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

1 reference

12 December 2020

Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment.

1 reference

12 December 2020

Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127.

1 reference

12 December 2020

Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial

1 reference

12 December 2020

Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer

1 reference

12 December 2020

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial.

1 reference

12 December 2020

Over-DI dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patients.

1 reference

12 December 2020

Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials

1 reference

12 December 2020

Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction

1 reference

12 December 2020

Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study).

1 reference

12 December 2020

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

1 reference

12 December 2020

Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma.

1 reference

12 December 2020

Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials

1 reference

12 December 2020

Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801).

1 reference

12 December 2020

Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study

1 reference

12 December 2020

Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses

1 reference

12 December 2020

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

1 reference

12 December 2020

Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer

1 reference

12 December 2020

Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study

1 reference

12 December 2020

Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group

1 reference

12 December 2020

Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study).

1 reference

12 December 2020

10.1007/S11912-010-0101-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20425077%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference